Methylenedioxyhydroxyethylamphetamine

Last updated
MDHOET
MDHOET svg.svg
Names
Preferred IUPAC name
2-{[(2H-1,3-Benzodioxol-5-yl)propan-2-yl]amino}ethan-1-ol
Other names
3,4-Methylenedioxy-N-hydroxyethylamphetamine
3,4-Methylenedioxy-1-(alpha-methylaminohydroxyethyl)ethane
MDOHET, MDHET, MDHEA
Identifiers
3D model (JSmol)
ChemSpider
PubChem CID
UNII
  • InChI=1S/C12H17NO3/c1-9(13-4-5-14)6-10-2-3-11-12(7-10)16-8-15-11/h2-3,7,9,13-14H,4-6,8H2,1H3 X mark.svgN
    Key: SCUUYKMQDUDNBP-UHFFFAOYSA-N X mark.svgN
  • C1=C2C(=CC=C1CC(C)NCCO)OCO2
Properties
C12H17NO3
Molar mass 223.271 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

MDHOET, or 3,4-methylenedioxy-N-hydroxy ethyl amphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-hydroxy ethyl analogue of MDA. MDHOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved) , the minimum dosage is listed as 50 mg. MDHOET produces few to no effects. Very little data exists about the pharmacology, pharmacokinetics, effects, and toxicity of MDHOET.

Contents

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act. [1]

See also

References

  1. ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.